Testing services

Ended Purchase Order Awarded Last action

Contract number
75N91024P00005
Awardee
Awarding agency
Obligated
$19,123

Award facts

Contract value 100% obligated
$19,123.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Switzerland

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $5,000
Original award $14,123

About this award

Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide testing services in support of biomedical research projects involving high throughput data analysis. With a potential value of $19,123, this purchase order has a completion date of March 14, 2024 and was awarded on November 1, 2023. No major subcontractors or set aside designations were specified. Engene Statistics Sagl will leverage its expertise in data analytics and statistical consulting for life sciences to deliver the requested testing services from its location in Switzerland to aid the National Cancer Institute's efforts in advancing cancer research.

Quick answers

Who was awarded contract 75N91024P00005?

75N91024P00005 was awarded to Engene Statistics GMBH by National Cancer Institute (National Institutes of Health) on November 1, 2023.

How much is contract 75N91024P00005 worth?

The government has obligated $19,123 on 75N91024P00005.

Was contract 75N91024P00005 competed?

The extent of competition for 75N91024P00005 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award